CEO ups stake in Bulgarian drug maker Sopharma

Donev acquired 8,600 Sopharma shares at a weighted average price of 3.4051 levs ($1.95/1.74 euro) on December 30, after selling 1,650 shares at a price of 3.3827 levs on December 27, the drug maker said in two filings to the Bulgarian Stock Exchange.

At the end of September, Donev held a stake of below 5% in Sopharma directly, according to the company's most recent interim financial statement.

Indirectly, Donev is the biggest shareholder in Sopharma, as he controls a 25.39% stake through his company Donev Investments Holding. Donev is also a major shareholder in Sopharma's second biggest shareholder - Telecomplect Invest. Telecomplect Invest controls 20.68% interest in Sopharma.

As at 9:30 CET on Thursday, Sopharma shares traded 0.59% higher at 3.42 levs on the Bulgarian Stock Exchange.

(1 euro = 1.95583 levs)